Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
111 Inc (YI US)
Watchlist
124
Analysis
Information Technology
•
China
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription, and other services. 111 serves patients in China.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
JSR Corp
•
07 Aug 2023 00:17
Merger Arb Mondays (07 Aug) - JSR, ITOCHU, Allkem, Origin, Symbio, Pacific Current, United Malt, MPI
This week, the highest gross spreads are 111 (19.6%), Chindata (15.3%), Estia (12.7%), InvoCare (10.4%), ENM (9.4%), Eoflow (7.7%), JSR (7.2%),...
Arun George
Follow
549 Views
Share
bullish
•
Allkem Ltd
•
06 Aug 2023 07:00
(Mostly) Asia-Pac Weekly Risk Arb Wrap: Itochu Techno, Superloop/Symbio, Dali Foods, Allkem, Oishi
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
564 Views
Share
bullish
•
Rakuten
•
23 Jul 2023 15:51
Weekly Deals Digest (23 Jul) - Rakuten Securities, Tryt, EbixCash, Lalatech, 111, Newcrest, Origin
Last week, notable developments occurred in Event-Driven (111, Healius, InvoCare, Newcrest, Origin Energy) and ECM (Rakuten Securities, Tryt,...
Arun George
Follow
562 Views
Share
bullish
•
111 Inc
•
23 Jul 2023 13:52
111 (YI US): The Privatisation Offer Gets a Reboot
The revamped consortium facilitates the signing of a definite agreement. The consortium represents 95.27% of the voting power, which ensures a...
Arun George
Follow
698 Views
Share
bullish
•
Chindata Group
•
17 Jul 2023 00:39
Merger Arb Mondays (17 Jul) - Chindata, Eoflow, JSR, IMAX, Mason, Estia, Musgrave, Origin, InvoCare
This week, the highest gross spreads are 111 (27.5%), Chindata (15.0%), ENM (11.5%), Estia (9.6%), Poly Culture (7.8%), Costa (7.3%), Eoflow...
Arun George
Follow
672 Views
Share
First
Previous
8
9
10
11
12
13
14
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x